Myleugyne (Econazole Nitrate)

Myleugyne contains econazole nitrate, an imidazole antifungal that targets fungal infections of the skin and superficial layers.

• Dermatophytosis (tinea corporis, tinea pedis, tinea cruris): reduces fungal growth and promotes resolution of lesions.
• Cutaneous candidiasis: eradicates yeast overgrowth on the skin, relieving erythema and itching.
• Seborrheic dermatitis: controls Malassezia proliferation, decreasing scaling and redness.

• Econazole nitrate inhibits ergosterol synthesis by blocking the fungal cytochrome P450 enzyme lanosterol 14α‑demethylase. This disruption compromises the fungal cell membrane, leading to increased permeability and ultimately cell death, thereby limiting the spread of the infection on the skin surface.

Topical application of Myleugyne may be associated with local skin reactions.

Common Side Effects

• Itching: mild to moderate pruritus at the application site.
• Burning sensation: transient warmth or stinging after use.
• Redness: localized erythema.
• Scaling: mild flaking of the treated area.
• Dryness: temporary loss of skin moisture.
• Contact dermatitis: localized allergic response.

Serious or Rare Side Effects

• Severe allergic reaction: swelling, hives, or anaphylaxis.
• Blistering: formation of vesicles or bullae.
• Extensive swelling: edema beyond the application site.
• Urticaria: widespread hives.
• Stevens‑Johnson syndrome: rare severe mucocutaneous reaction.
• Systemic toxicity: extremely rare systemic absorption leading to hepatic or renal effects.

Before using Myleugyne, consider the following safety measures.

• Apply to intact skin only: avoid broken or inflamed areas.
• Avoid eyes and mucous membranes: rinse thoroughly if contact occurs.
• Do not use on large body surface areas without medical supervision: excessive absorption may occur.
• Monitor for allergic reactions: discontinue if severe irritation develops.
• Use with caution in immunocompromised patients: infection may be more severe.
• Store at room temperature: keep in the original container, protect from moisture and light.

Myleugyne may interact with other topical agents or systemic medications.

Major Interactions (Avoid)

• Concurrent use of other topical azole antifungals: may increase local irritation.
• Systemic azole therapy (e.g., fluconazole, itraconazole): could enhance systemic absorption and toxicity.

Moderate Interactions (Monitor Closely)

• Topical corticosteroids applied to the same area: may mask infection signs.
• Occlusive dressings over the treated skin: can increase drug absorption.
• Use with warfarin or other anticoagulants: monitor for any unexpected bleeding, although interaction is uncommon.